Fanny Moncoq
28 Rue Du Dr. Roux
Paris, 75015, France
Paris, 75015, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Eradication of pre-clinical prostate tumors by a lentiviral vector-based immunotherapy.
Journal: Molecular therapy. Oncology
Published: March 09, 2026
Lentiviral vector-based T-cell vaccines against Zika and yellow fever viruses.
Journal: Vaccine
Published: April 23, 2025
A lentiviral vector targeting a KRAS neoepitope for cancer immunotherapy.
Journal: Scientific reports
Published: March 17, 2025
T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector.
Journal: NPJ vaccines
Published: November 30, 2023
Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue viruses.
Journal: Frontiers in immunology
Published: April 18, 2023
Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine.
Journal: EMBO molecular medicine
Published: March 20, 2023
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 13, 2022
A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4+ T-cell immunity.
Journal: Mucosal immunology
Published: October 21, 2021
A lentiviral vector encoding fusion of light invariant chain and mycobacterial antigens induces protective CD4+ T cell immunity.
Journal: Cell reports
Published: June 10, 2021
Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice.
Journal: EMBO molecular medicine
Published: April 22, 2021
Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models.
Journal: Cell host & microbe
Published: September 08, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026